TP53 and metastatic neoplasm: It is not surprising that tumor size is a reliable prognostic indicator in patients with germline TP53 variants, in which patients with small tumors (<100 g) have excellent outcomes (34–36) whereas those with large tumors can have metastatic disease at diagnosis and a high relapse rate after complete resection.